Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -5.58%505.65M | -9.22%1B | -7.52%535.53M | 2.15%1.1B | 7.72%579.1M | 6.30%1.08B | 12.96%537.59M | 10.74%1.02B | 5.29%475.92M | 4.14%916.75M |
| Operating income | -5.58%505.65M | -9.22%1B | -7.52%535.53M | 2.15%1.1B | 7.72%579.1M | 6.30%1.08B | 12.96%537.59M | 10.74%1.02B | 5.29%475.92M | 4.14%916.75M |
| Cost of sales | 6.49%-372.69M | 9.49%-745.1M | 6.46%-398.55M | -1.21%-823.27M | -2.93%-426.06M | -2.53%-813.44M | -12.58%-413.92M | -9.81%-793.4M | -3.99%-367.65M | -5.44%-722.55M |
| Operating expenses | 6.49%-372.69M | 9.49%-745.1M | 6.46%-398.55M | -1.21%-823.27M | -2.93%-426.06M | -2.53%-813.44M | -12.58%-413.92M | -9.81%-793.4M | -3.99%-367.65M | -5.44%-722.55M |
| Gross profit | -2.93%132.96M | -8.42%255.65M | -10.50%136.98M | 5.02%279.15M | 23.75%153.04M | 19.82%265.8M | 14.23%123.67M | 14.23%221.84M | 9.97%108.26M | -0.42%194.2M |
| Selling expenses | 3.84%-77.4M | -0.22%-158.23M | -3.95%-80.49M | 0.40%-157.88M | 1.92%-77.43M | -8.66%-158.53M | -11.55%-78.95M | -3.36%-145.89M | -5.69%-70.77M | 8.82%-141.15M |
| Administrative expenses | 6.09%-42.99M | 8.14%-89.69M | 9.12%-45.77M | -1.64%-97.64M | -7.71%-50.36M | -13.48%-96.06M | -14.70%-46.76M | -9.27%-84.65M | -1.81%-40.77M | 7.44%-77.47M |
| Revaluation surplus | 23.25%-4.61M | -115.42%-12.6M | -13.33%-6M | -199.68%-5.85M | 14.89%-5.3M | -58.92%5.87M | ---6.22M | -26.31%14.28M | ---- | 640.31%19.38M |
| -Changes in the fair value of investment property | 23.25%-4.61M | -115.42%-12.6M | -13.33%-6M | -199.68%-5.85M | 14.89%-5.3M | -58.92%5.87M | ---6.22M | -26.31%14.28M | ---- | 640.31%19.38M |
| Impairment and provision | 34.49%-2.5M | -89.62%-7.91M | -202.78%-3.82M | -154.89%-4.17M | -1,870.31%-1.26M | -202.40%-1.64M | 80.12%-64K | 83.98%-541K | ---322K | 58.74%-3.38M |
| -Impairment of property, machinery and equipment | 3.89%-2.22M | -51.94%-6.34M | -83.43%-2.31M | -139.66%-4.17M | -646.15%-1.26M | -189.04%-1.74M | ---169K | 79.99%-602K | ---- | 63.26%-3.01M |
| -Other impairment is provision | 81.53%-278K | ---1.57M | ---1.51M | ---- | ---- | 70.49%104K | 132.61%105K | 116.49%61K | ---322K | ---370K |
| Special items of operating profit | -15.26%9.17M | -1.88%19.91M | 4.88%10.82M | -35.72%20.29M | -47.76%10.31M | 64.16%31.56M | 125.13%19.74M | -57.96%19.23M | -69.43%8.77M | 102.71%45.73M |
| Operating profit | 24.94%14.63M | -78.94%7.14M | -59.63%11.71M | -27.90%33.9M | 154.01%29M | 93.69%47.01M | 120.81%11.42M | -34.97%24.27M | -74.32%5.17M | 214.23%37.33M |
| Financing cost | -41.29%-1.49M | -21.78%-2.99M | 4.00%-1.06M | 2.07%-2.46M | 15.25%-1.1M | 14.55%-2.51M | 14.38%-1.3M | -2.87%-2.94M | -8.36%-1.52M | 15.57%-2.85M |
| Earning before tax | 23.32%13.14M | -86.81%4.15M | -61.82%10.65M | -29.35%31.44M | 175.72%27.9M | 108.58%44.5M | 176.88%10.12M | -38.11%21.34M | -80.49%3.66M | 195.61%34.47M |
| Tax | -27.97%-4.59M | -1,082.10%-6.21M | -315.04%-3.59M | 74.59%-525K | -21.90%1.67M | 45.33%-2.07M | 524.85%2.14M | -49.72%-3.78M | 28.04%-503K | -158.22%-2.52M |
| After-tax profit from continuing operations | 20.95%8.54M | -106.66%-2.06M | -76.11%7.06M | -27.15%30.92M | 141.27%29.57M | 141.70%42.44M | 288.86%12.26M | -45.05%17.56M | -82.52%3.15M | 200.72%31.95M |
| Earning after tax | 20.95%8.54M | -106.66%-2.06M | -76.11%7.06M | -27.15%30.92M | 141.27%29.57M | 141.70%42.44M | 288.86%12.26M | -45.05%17.56M | -82.52%3.15M | 200.72%31.95M |
| Minority profit | -108.45%-148K | -77.74%258K | -108.60%-71K | -28.72%1.16M | 3,833.33%826K | 394.03%1.63M | -86.54%21K | 67.22%-553K | 124.76%156K | 35.76%-1.69M |
| Profit attributable to shareholders | 21.82%8.69M | -107.78%-2.32M | -75.18%7.14M | -27.09%29.76M | 134.93%28.75M | 125.35%40.81M | 308.41%12.24M | -46.16%18.11M | -83.95%3M | 215.61%33.64M |
| Basic earnings per share | 21.67%0.0073 | -107.97%-0.002 | -75.31%0.006 | -27.03%0.0251 | 135.92%0.0243 | 124.84%0.0344 | 312.00%0.0103 | -46.13%0.0153 | -84.08%0.0025 | 215.92%0.0284 |
| Diluted earnings per share | 21.67%0.0073 | -107.97%-0.002 | -75.31%0.006 | -27.03%0.0251 | 135.92%0.0243 | 124.84%0.0344 | 312.00%0.0103 | -46.13%0.0153 | -84.08%0.0025 | 215.92%0.0284 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PwC Accounting Firm | -- | PwC Accounting Firm | -- | PwC Accounting Firm | -- | PwC Accounting Firm | -- | PwC Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.